Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy (Q35597931)

9 August 2017

1 reference

title

Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy (English)

1 reference

9 August 2017

Mariko Kawakami

1

1 reference

9 August 2017

Koji Kawakami

series ordinal

2

1 reference

9 August 2017

Raj K Puri

series ordinal

3

1 reference

9 August 2017

1 October 2003

1 reference

Journal of Neuro-Oncology

9 August 2017

1 reference

9 August 2017

65

1 reference

9 August 2017

1

1 reference

9 August 2017

15-25

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1026294416718

9 August 2017

0 references

cites work

Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.

1 reference

12 December 2020

Interleukin-4 and cancer therapy

1 reference

12 December 2020

Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID

1 reference

12 December 2020

Expression of Interleukin 13 Receptor in Glioma and Renal Cell Carcinoma: IL13Rα2 as a Decoy Receptor for IL13

1 reference

12 December 2020

The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway

1 reference

12 December 2020

Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor

1 reference

12 December 2020

Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex

1 reference

12 December 2020

Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo.

1 reference

12 December 2020

Structure of and signal transduction through interleukin-4 and interleukin-13 receptors (review).

1 reference

12 December 2020

Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain

1 reference

12 December 2020

Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor

1 reference

12 December 2020

Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo.

1 reference

12 December 2020

Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors

1 reference

12 December 2020

Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells

1 reference

12 December 2020

The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1

1 reference

12 December 2020

Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein

1 reference

12 December 2020

Overexpressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy

1 reference

12 December 2020

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors.

1 reference

12 December 2020

Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells

1 reference

12 December 2020

Designing immunotoxins for cancer therapy.

1 reference

12 December 2020

A wide range of human cancers express interleukin 4 (IL4) receptors that can be targeted with chimeric toxin composed of IL4 and Pseudomonas exotoxin

1 reference

12 December 2020

Increased antitumor activity of a circularly permuted interleukin 4-toxin in mice with interleukin 4 receptor-bearing human carcinoma.

1 reference

12 December 2020

Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas.

1 reference

12 December 2020

In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice

1 reference

12 December 2020

Inhibition of colon and breast carcinoma cell growth by interleukin-4

1 reference

12 December 2020

Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15

1 reference

12 December 2020

Increased sophistication of immunotoxins

1 reference

12 December 2020

Human renal cell carcinoma cells are sensitive to the cytotoxic effect of a chimeric protein composed of human interleukin-4 and Pseudomonas exotoxin

1 reference

12 December 2020

Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily

1 reference

12 December 2020

A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesis.

1 reference

12 December 2020

Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma.

1 reference

12 December 2020

Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4

1 reference

12 December 2020

Targeting interleukin-4 receptors for effective pancreatic cancer therapy

1 reference

12 December 2020

Recombinant immunotoxins in targeted cancer cell therapy

1 reference

12 December 2020

In vitro and in vivo suppression of interleukin-2-activated killer cell activity by chimeric proteins between interleukin-2 and Pseudomonas exotoxin

1 reference

12 December 2020

A circularly permuted recombinant interleukin 4 toxin with increased activity

1 reference

12 December 2020

Design and application of a cytokine-receptor-based interaction trap

1 reference

12 December 2020

Recombinant toxins as novel therapeutic agents

1 reference

12 December 2020

Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model

1 reference

12 December 2020

The IL-4 receptor: signaling mechanisms and biologic functions

1 reference

12 December 2020

Internalization property of interleukin-4 receptor alpha chain increases cytotoxic effect of interleukin-4 receptor-targeted cytotoxin in cancer cells

1 reference

12 December 2020

Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15.

1 reference

12 December 2020

In vivo expression of the interleukin 4 receptor alpha by astrocytes in epilepsy cerebral cortex.

1 reference

12 December 2020

Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells

1 reference

12 December 2020

IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.

1 reference

12 December 2020

Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy

1 reference

12 December 2020

Interleukin-4: a prototypic immunoregulatory lymphokine

1 reference

12 December 2020

In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures

1 reference

12 December 2020

Tumor necrosis factor upregulates interleukin-4 receptors on murine sarcoma cells

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1026294416718

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference